Mental health professionals’ perspective on the use of esketamine in treatment-resistant depression and their motivation to adopt it: a Saudi cross-sectional study
Despite significant interest, actual adoption of esketamine is low, mainly due to logistical barriers, high costs, and availability issues. Concerns about side effects and potential misuse are also linked to hesitation. Accordingly, interventions to address the obstacles and concerns are needed.
Authors
- Ayedh H. Alghamdi (ORCID: https://orcid.org/0009-0009-5452-0961)
- Mohammed Abdul-Aziz Ghaith
- Mohammed A. Aljaffer (ORCID: https://orcid.org/0000-0002-0345-5567)
- Saleh A. Alghamdi (ORCID: https://orcid.org/0000-0003-3264-7397)
- Ahmad H. Almadani (ORCID: https://orcid.org/0000-0003-4490-3220)
- Saleh Ibrahim Alfawaz
- Gosay M. Almazyad
- Ali A. Alshehri
Institutions
- Imam Mohammad ibn Saud Islamic University (SA)
- King Saud Medical City (SA)
- King Saud University (SA)
- Islamic University (BD)
- Bupa UK Foundation (GB)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2026-02-27
- DOI
- https://doi.org/10.3389/fpsyt.2026.1726411
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00